NasdaqCM - Delayed Quote USD

Aeterna Zentaris Inc. (AEZS)

1.9562 -0.0338 (-1.70%)
At close: April 26 at 4:00 PM EDT
1.9500 -0.01 (-0.32%)
After hours: April 26 at 4:28 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,498.0000
4,498.0000
5,640.0000
5,260.0000
3,652.0000
Cost of Revenue
222.0000
222.0000
157.0000
90.0000
2,317.0000
Gross Profit
4,276.0000
4,276.0000
5,483.0000
5,170.0000
1,335.0000
Operating Expense
22,284.0000
22,284.0000
20,736.0000
13,841.0000
7,399.0000
Operating Income
-18,008.0000
-18,008.0000
-15,253.0000
-8,671.0000
-6,064.0000
Net Non Operating Interest Income Expense
1,126.0000
1,126.0000
--
--
-736.0000
Other Income Expense
330.0000
330.0000
-7,474.0000
194.0000
2,077.0000
Pretax Income
-16,552.0000
-16,552.0000
-22,727.0000
-8,477.0000
-4,723.0000
Tax Provision
--
--
--
-109.0000
395.0000
Net Income Common Stockholders
-16,552.0000
-16,552.0000
-22,727.0000
-8,368.0000
-5,118.0000
Diluted NI Available to Com Stockholders
-16,552.0000
-16,552.0000
-22,727.0000
-8,368.0000
-5,118.0000
Basic EPS
-4.81
-3.41
-4.68
-1.82
-3.11
Diluted EPS
-4.81
-3.41
-4.68
-1.82
-3.11
Basic Average Shares
4,855.8760
4,855.8760
4,855.8760
4,596.9800
1,643.3270
Diluted Average Shares
4,855.8760
4,855.8760
4,855.8760
4,596.9800
1,643.3270
Total Operating Income as Reported
-18,008.0000
-18,008.0000
-23,603.0000
-8,671.0000
-5,706.0000
Total Expenses
22,506.0000
22,506.0000
20,893.0000
13,931.0000
9,716.0000
Net Income from Continuing & Discontinued Operation
-16,552.0000
-16,552.0000
-22,727.0000
-8,368.0000
-5,118.0000
Normalized Income
-16,895.0000
-16,895.0000
-15,256.0000
-8,580.2355
-6,644.5950
Interest Income
1,126.0000
1,126.0000
--
--
--
Interest Expense
--
--
3.0000
21.0000
736.0000
Net Interest Income
1,126.0000
1,126.0000
--
--
-736.0000
EBIT
-18,008.0000
-18,008.0000
-15,253.0000
-8,671.0000
-3,987.0000
EBITDA
-17,839.0000
-17,839.0000
-15,118.0000
-8,526.0000
-3,755.0000
Reconciled Cost of Revenue
222.0000
222.0000
157.0000
90.0000
2,317.0000
Reconciled Depreciation
169.0000
169.0000
135.0000
145.0000
232.0000
Net Income from Continuing Operation Net Minority Interest
-16,552.0000
-16,552.0000
-22,727.0000
-8,368.0000
-5,118.0000
Total Unusual Items Excluding Goodwill
343.0000
343.0000
-7,471.0000
215.0000
2,077.0000
Total Unusual Items
343.0000
343.0000
-7,471.0000
215.0000
2,077.0000
Normalized EBITDA
-18,182.0000
-18,182.0000
-7,647.0000
-8,741.0000
-5,832.0000
Tax Rate for Calcs
--
--
--
0.0000
0.0003
Tax Effect of Unusual Items
--
--
--
2.7645
550.4050
12/31/2020 - 5/10/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LIPO Lipella Pharmaceuticals Inc.
0.7110
+0.98%
 
ACST Acasti Pharma Inc.
2.9000
-2.03%
 
ARTL Artelo Biosciences, Inc.
1.3399
+0.74%
 
CZO.V Ceapro Inc.
0.2600
+8.33%
 
MRKR Marker Therapeutics, Inc.
4.2900
-4.24%
 
KTTA Pasithea Therapeutics Corp.
7.24
0.00%
 
DRTS Alpha Tau Medical Ltd.
2.4050
+0.21%
 
DRUG Bright Minds Biosciences Inc.
1.1000
0.00%
 
SLRX Salarius Pharmaceuticals, Inc.
0.4951
+2.93%
 
TTNP Titan Pharmaceuticals, Inc.
7.09
+0.57%